Physician profile
Son D Le
NPI 1568493062
$28,450.50
in general payments reported to CMS, 2019-2025
62 companies · $5,050 in 2025
The $5,050 reported for 2025 was more than what 97% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,801 · 2020: $2,583 · 2021: $4,748 · 2022: $4,521 · 2023: $3,656 · 2024: $4,090 · 2025: $5,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,333 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,449.70 |
| Travel and Lodging | $1,332.91 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,778.64 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Medtronic, INC. | $3,604.50 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $2,660.04 | 2019-2025 | Proclaim, Octrode, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,880.50 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $1,270.36 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $1,228.32 | 2021-2025 | |
| Lundbeck LLC | $912.61 | 2020-2025 | Vyepti |
| Tersera Therapeutics LLC | $810.05 | 2019-2025 | Prialt |
| Nevro Corp. | $802.19 | 2019-2024 | Senza |
| Globus Medical, INC. | $763.83 | 2025 | Senza |
| Saluda Medical Americas, INC. | $720.01 | 2023-2025 | Evoke, Evoke Scs |
| Vertiflex, INC. | $696.61 | 2019 | |
| Protega Pharmaceutials INC | $591.60 | 2022-2025 | Roxybond |
| Genesys Orthopedics Systems, L.L.C. | $506.58 | 2021 | |
| Ibsa Pharma INC. | $468.54 | 2021-2025 | Tirosint, Licart, Tirosint |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $468.53 | 2019-2020 | |
| Allergan, INC. | $429.58 | 2019-2021 | |
| Grt US Holding, INC. | $426.26 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $412.57 | 2019-2025 | Ztlido |
| Mdd US Operations, LLC | $412.33 | 2019-2021 | |
| Nalu Medical, INC. | $405.27 | 2020-2024 | Nalu Neurostimulation System |
| Flowonix Medical Incorporated | $286.28 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $280.91 | 2022 | |
| Amgen INC. | $246.10 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $238.42 | 2020-2025 | |
| Averitas Pharma INC. | $229.55 | 2023-2025 | Qutenza |
| Biohaven Pharmaceuticals, INC. | $215.38 | 2021 | |
| Spr Therapeutics, INC | $196.37 | 2022 | |
| Csl Behring | $177.62 | 2022-2023 | Hizentra |
| Virtus Pharmaceuticals LLC | $176.95 | 2020-2021 | |
| Lilly USA, LLC | $174.68 | 2019-2023 | Emgality |
| Novartis Pharmaceuticals Corporation | $172.43 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $140.67 | 2019-2024 | Dysport |
| Daiichi Sankyo INC. | $129.57 | 2019 | |
| Biodelivery Sciences International, INC. | $115.17 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $112.82 | 2021-2024 | Ryaltris, Kloxxado |
| Azurity Pharmaceuticals, INC. | $110.45 | 2023-2025 | Horizant, Horizant |
| Curonix LLC | $87.90 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Therapeutics, INC. | $83.44 | 2020-2021 | |
| Electronic Waveform Lab, INC. | $81.63 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $80.75 | 2019-2021 | |
| Radius Health, INC. | $80.11 | 2019-2021 | |
| Assertio Therapeutics, INC. | $79.28 | 2019-2020 | |
| Painteq LLC | $78.70 | 2022 | |
| Uswm, LLC | $63.44 | 2021 | |
| Almatica Pharma LLC | $54.90 | 2021 | |
| Vertos Medical, INC. | $54.87 | 2023-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $46.09 | 2025 | Prospera |
| Shionogi INC | $45.87 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $42.93 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $42.18 | 2022-2025 | Xeomin |
| Sentynl Therapeutics, INC. | $41.00 | 2019-2020 | |
| Si-Bone, INC. | $40.93 | 2025 | |
| Revance Therapeutics, INC. | $37.70 | 2024 | Daxxify |
| Depuy Synthes Sales INC. | $37.14 | 2024 | Peak, Orthovisc, Monovisc |
| Organogenesis INC. | $24.90 | 2021 | |
| Redhill Biopharma INC. | $21.62 | 2022 | |
| Merz North America, INC. | $19.46 | 2019 | |
| Bioventus LLC | $14.90 | 2019 | |
| Stimwave Technologies Incorporated | $14.55 | 2019 | |
| Bausch Health US, LLC | $12.36 | 2020 | |
| Piramal Critical Care | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.